See also this year's filing and all EDGAR filings for this company.
PDF Report 0001498068_2020_American_Renal_Associates_Holdings_Inc.pdf
Logs
| warning | Similarly named company. Duplicate? | None | {'details': [{'other_company': 'AMERICAN INTERNATIONAL HOLDINGS CORP.', 'shared_tokens': {'american'}}]} |
| info | Failed to set obs_EconomicCapitalRatio | industry.us_generic | {'reason': "KeyError('0001498068')"} |
| info | Added remainder_ComprehensiveNetIncome directly from 10K | industry.us_generic | {} |
Graph
Absolute values for 0001498068, American Renal Associates Holdings Inc.
| xvar | xval | |
|---|---|---|
| 0 | IntangibleAssets | 563,095,000 |
| 1 | AssetsNonCurrent | 152,507,000 |
| 2 | AssetsCurrent | 220,014,000 |
| 3 | PropertyPlantAndEquipment | 0 |
| 4 | remainder_Assets | 151,175,000 |
| 5 | LongTermLiabilities | 679,128,000 |
| 6 | LiabilitiesCurrent | 193,641,000 |
| 7 | remainder_Liabilities | 3,000,000 |
| 8 | LaborExpense | 0 |
| 9 | CostOfGoodsAndServicesSold | 0 |
| 10 | GeneralAndAdministrativeExpense | 91,081,000 |
| 11 | GoodwillImpairmentLoss | 0 |
| 12 | OperatingCostsAndExpenses | 610,179,000 |
| 13 | DepreciationDepletionAndAmortization | 43,765,000 |
| 14 | SellingAndMarketingExpense | 0 |
| 15 | ResearchAndDevelopmentExpense | 0 |
| 16 | remainder_Expenses | 51,573,000 |
| 17 | remainder_Revenues | 822,522,000 |
| 18 | remainder_NetIncome | 221,000 |
| 19 | remainder_ComprehensiveNetIncome | -41,630,000 |
| yvar | yval | |
|---|---|---|
| 0 | Assets | 1,086,791,000 |
| 1 | Liabilities | 875,769,000 |
| 2 | Expenses | 796,598,000 |
| 3 | Revenues | 822,522,000 |
| 4 | StockholdersEquity | 211,022,000 |
| 5 | NetIncome | 26,145,000 |
| 6 | ComprehensiveNetIncome | -15,485,000 |
| 7 | BaseVar | 2,085,825,715 |
| 8 | EconomicCapitalRatio | 0.342 |
Edgar->Model Mapping
Feature Distribution
Change over Time
